Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia

Final appraisal determination document Final published guidance  TA132 (PDF 766 KB)

Assessment report Addendum  TA132 (PDF 681 KB)

Assessment report  TA132 (PDF 1.51 MB)

Assessment report 2  TA132 (PDF 306 KB)

Assessment report Overview 2  TA132 (PDF 89 KB)

Equality Impact Assessment (Guidance development) (PDF 173 KB)

Final appraisal determination

Final appraisal determination document (PDF 333 KB)

Committee papers (PDF 1.98 MB)

Appraisal consultation document (PDF 568 KB)

Committee papers (PDF 8.33 MB)

Final matrix (MSWord 74 KB)

Final scope (PDF 104 KB)

NICE response to comments on the draft scope and provisional matrix (PDF 172 KB)

Provisional matrix (post referral) (PDF 156 KB)

Draft scope (post referral) (PDF 169 KB)